Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study
Ryan J.O. Dowling(University Health Network), Vuk Stambolic(Ontario Institute for Cancer Research)
Cited by 118
Related Papers
Nuclear PTEN Controls DNA Repair and Sensitivity to Genotoxic Stress
|Science|2013|410
Metformin in cancer: translational challenges
|Journal of Molecular Endocrinology|2012|351
The Rho Guanine Nucleotide Exchange Factor DRhoGEF2 Is a Genetic Modifier of the PI3K Pathway in Drosophila
|PLoS ONE|2016|4
NEK10 tyrosine phosphorylates p53 and controls its transcriptional activity
|bioRxiv (Cold Spring Harbor Laboratory)|2019|3
The role of mTOR signalling in translational control and cancer
|Library and Archives Canada (Government of Canada)|2009|0